Loomba, Rohit; Schattenberg, Joern M.; Taub, Rebecca A. et al.
RELATIONSHIP OF NON-INVASIVE MEASURES WITH HISTOLOGICAL RESPONSE IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS AND FIBROSIS: 52-WEEK DATA FROM THE PHASE 3 MAESTRO-NASH TRIALHEPATOLOGY. Bd. 78. 2023 S. S155-S159
Labenz, Christian; Lammert, Frank; Galle, Peter R.
Reply to: "SEAL: Why was this approach not effective?"JOURNAL OF HEPATOLOGY. Bd. 78. H. 1. 2023 S. E27-E28
Labenz, Christian; Lammert, Frank; Galle, Peter R.
Reply to: "SEAL: Why was this approach not effective?"JOURNAL OF HEPATOLOGY. Bd. 78. H. 1. 2023 S. E27-E28
Iruzubieta, Paula; Bataller, Ramon; Arias-Loste, Maria Teresa et al.
Research Priorities for Precision Medicine in NAFLDCLINICS IN LIVER DISEASE. Bd. 27. H. 2. 2023 S. 535-551
Chevallay, Mickael; Berlth, Felix; De Manzoni, Giovanni et al.
Resection margin strategy in gastric cancer surgery: the European REMARCS (Resection MARgin for Cancer of the Stomach) surveyBRITISH JOURNAL OF SURGERY. Bd. 110. 2023
Harrison, Stephen A.; Bedossa, Pierre; Guy, Cynthia D. et al.
RESMETIROM TREATMENT HELPS RESTORE THYROID HORMONE LEVELS IN PATIENTS WITH NONALCOHOLIC STEATOHEPATITIS: 52-WEEK DATA FROM THE PHASE 3 MAESTRONASH TRIALHEPATOLOGY. Bd. 78. 2023 S. S1213-S1219
Dreher, Matthias; Witte, Torsten; Hoeper, Kirsten et al.
Rheuma-VOR study: optimising healthcare of rheumatic diseases by multiprofessional coordinating centresANNALS OF THE RHEUMATIC DISEASES. 2023
Ben Khaled, Najib; Moeller, Marie; Jochheim, Leonie et al.
Risk of bleeding and thromboembolic events with atezolizumab/bevacizumab or lenvatinib in patients with hepatocellular carcinoma: a multicenter, retrospective studyJOURNAL OF HEPATOLOGY. Bd. 78. 2023 S. S51-S51
Wester, Axel; Schoenau, Johanna; Schattenberg, Joern et al.
Risk of cancer and subsequent mortality in primary biliary cholangitis: a population-based cohort study of 3,052 patientsJOURNAL OF HEPATOLOGY. Bd. 78. 2023 S. S46-S46
Schoenau, Johanna; Wester, Axel; Schattenberg, Joern M. et al.
Risk of fractures and postfracture mortality in 3980 people with primary biliary cholangitis: A population-based cohort studyJOURNAL OF INTERNAL MEDICINE. Bd. 294. H. 2. 2023 S. 164-177